Letter to the Editor: Does CD34+ Cell Selection Enrich Malignant Stem Cells in B Cell (and Other) Malignancies?

Journal of Hematotherapy

Volumn 5, Issue 2, 1996, Pages 97-98

  Reading, Christopher L ^a   Gazitt, Yair ^b   Estrov, Zeev ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; LEUKOCYTE ANTIGEN;

B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BREAST TUMOR; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; LETTER; LYMPHOCYTE DEPLETION; MULTIPLE MYELOMA; PATHOLOGY; PHENOTYPE;

ANTIGENS, CD; ANTIGENS, CD34; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BREAST NEOPLASMS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, B-CELL; LYMPHOCYTE DEPLETION; LYMPHOMA, B-CELL; MULTIPLE MYELOMA; PHENOTYPE;

EID: 0030122008     PISSN: 10616128     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.97     Document Type: Letter

References (11)

1. Pilarski, L.M. & Jensen, G.S. Monoclonal circulating B cells in multiple myeloma. Hematol. Oncol. Clin. North Am. 6:297, 1992.
2. Jelinek, D.F., Ahmann, G.J., Griepp P.R., et al. Coexistence of aneuploid myeloma cell line that exhibit clonal immunoglobulin gene rearrangement: Clinical implications. Cancer Res. 53:5320, 1993.
3. Belch, A.R., Bersagel, P.L., Szczepek, A., et al. CD34+B-cells in the blood of patients with MM express clonogenic IgH sequences. Blood 84:385a, 1994.
4. Takashita, M., Kosaka, M., Goto, T., et al. Cellular origin and extent of involvement in multiple myeloma: Genetic and phenotypic studies. Br. J. Hematol. 87:735, 1994.
5. Bergasgel, P.L., Belch, A.R. and Pilarski, L.M. The blood B-cells and bone marrow plasma cells in a patient with multiple myeloma include cells with the same N-ras mutation. Blood 84:524a, 1994.
6. Reading, C., Sasaki, D., Leemhuis, T., et al. Clinical scale purification of CD34+Thy+Lin- stem cells from mobilized peripheral blood by high speed fluorescence activated cell sorting for use as an autograft for multiple myeloma patients. Blood 84:399a, 1994.
7. Gazitt, Y., Reading, C.L., Hoffman, R., et al. Purified CD34+Lin-Thy+ stem cells do not contain clonal myeloma cells. Blood 86:381, 1995.
8. Estrov, Z., Zipf, T.F., O'Brien, S., et al. Identification of chronic lymphocytic leukemia (CLL) progenitor cells. Blood 84:458a, 1994.
9. Macintyre, E.A., Belanger, C. and Debert, C. Detection of clonal CD34+CD19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients. Blood 86:4691, 1995.
10. Kohler, G., Brugger, W., Schaefer, H.E., et al. Expression of CD34 stem cell antigen on tumor cells. Blood 84:497a, 1994.
11. Wessman, M., Schnell, J., VanDenBerg, D., et al. Fluorescent detection of metastatic breast cancer cells in bone marrow and mobilized peripheral blood by immunofluorescence and by high speed flow sorting. Blood 86:233a, 1995.